Loading...
Loading...
Among the 6 tracked institutional investors we monitor, SPRY (ARS PHARMACEUTICALS INC) is held with a combined value of $135.95M across 15,348,324 shares. The largest holder is VANGUARD GROUP INC with a position worth $40.88M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$135.95M
Total Shares Held
15,348,324
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $40.88M | 0.00% | New |
| 2 | BlackRock, Inc. | $40.25M | 0.00% | -1.4% |
| 3 | STATE STREET CORP | $29.27M | 0.00% | +13.1% |
| 4 | CITADEL ADVISORS LLC | $14.77M | 0.00% | -9.8% |
| 5 | Third Point LLC | $8.03M | 0.39% | +79.8% |
| 6 | FMR LLC | $2.75M | 0.00% | -14.3% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of SPRY with a position worth $40.88M, representing 0.00% of their portfolio. In total, 6 institutional investors hold SPRY with a combined value of $135.95M.
In the most recent quarter, 1 fund opened a new position in SPRY. Additionally, 2 increased their holdings and 3 reduced their positions.
Institutional investors hold $135.95M worth of SPRY stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $40.88M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SPRY, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SPRY positions.